Natasha S. Anstee

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

Journal: Nature cell biology
Published: June 30, 2025

Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Journal: Blood advances
Published: September 23, 2024

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Journal: Blood
Published: August 19, 2024

Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes.

Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes.

Journal: Genome research
Published: March 13, 2024

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 01, 2024

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.

Journal: Blood
Published: March 28, 2023

Iron regulatory protein (IRP)-mediated iron homeostasis is critical for neutrophil development and differentiation in the bone marrow.

Iron regulatory protein (IRP)-mediated iron homeostasis is critical for neutrophil development and differentiation in the bone marrow.

Journal: Science advances
Published: October 05, 2022

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

Journal: Cancer discovery
Published: April 15, 2022

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome.

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome.

Journal: Blood
Published: April 04, 2022

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Journal: Blood
Published: March 14, 2022

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Journal: Nature medicine
Published: February 19, 2022

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Journal: Blood
Published: November 29, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026